NovoCure Ltd — Director's Dealing 2019

Jan 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-01-15

Reporting Person: GROENHUYSEN WILHELMUS CM (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-15	Ordinary Shares	M	30000	$3.44	Acquired	67149	Direct
2019-01-15	Ordinary Shares	S	30000	$44.20	Disposed	37149	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-15	Options to Buy Ordinary Shares	$3.44	M	30000	Disposed	2021-12-13	Ordinary Shares (30000)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.

F2: Options exercised were fully vested as of the date hereof.